NDC 57894-501 – Rybrevant

Amivantamab 350 mg/1 · Injection · Intravenous

Human Prescription Drug

Product NDC57894-501

Product details

Brand name
Rybrevant
Generic name
Amivantamab-vmjw
Labeler
Janssen Biotech, Inc.
Dosage form
Injection
Route
Intravenous
Marketing category
BLA · BLA761210
Marketed since
May 21, 2021
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Rybrevant →

Package NDC codes (1)

Package NDCDescriptionSince
57894-501-011 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00)May 21, 2021